Harvest Fund Management Co., LTD Alnylam Pharmaceuticals, Inc. Transaction History
Harvest Fund Management Co., LTD
- $2.35 Billion
- Q3 2025
A detailed history of Harvest Fund Management Co., LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 2,021 shares of ALNY stock, worth $907,752. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,021
Previous 1,125
79.64%
Holding current value
$907,752
Previous $366,000
151.64%
% of portfolio
0.04%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding ALNY
# of Institutions
921Shares Held
117MCall Options Held
1.25MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA16.4MShares$7.38 Billion1.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$6.09 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.29 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.22MShares$3.24 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.04 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $55.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...